has_role 5-azacytidine 0 244.08077 244.207 cas:320-67-2 kegg.drug:D03021 5-azacytidine hmdb:HMDB0015063 4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one CHEBI:2038 4-amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one pubmed:29438107 pubmed:28486212 NCIt:C288 5-Azacytidine drugbank:DB00928 An <em>N</em>-glycosyl-1,3,5-triazine that is 4-amino-1,3,5-triazin-2(1<em>H</em>)-one substituted by a β-<small>D</small>-ribofuranosyl residue via an <em>N</em>-glycosidic linkage. An antineoplastic agent, it is used in the treatment of myeloid leukaemia. pubmed:15962522 azacitidinum MESH:D001374 5-azacytidine drugcentral:25 reaxys:620461 pubmed:28131982 wikipedia.en:Azacitidine Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1 4-amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one chebi_ontology Azacitidine C8H12N4O5 SNOMEDCT:88551000 lincs.smallmolecule:LSM-5218 pubmed:28415666 pubmed:11841042 patent:US2015038444 pubmed:17611569 kegg.compound:C11262 azacitidina NMUSYJAQQFHJEW-KVTDHHQDSA-N patent:KR20140069225 organic heterocyclic compound drug role